Today – on Rare Disease Day – the Government unveiled the England Rare Diseases Action Plan 2025. It marks a key step in maintaining momentum in the care and support of those affected by rare conditions before the UK Rare Diseases Framework expires in 2026. The Rare Diseases Action Plan outlines how the health system …
Interview with with Jenny Ousbey, originally published in Pharma IQ, to discuss key findings from OVID’s new report on pharma-patient engagement trends and how social media is reshaping the industry’s approach to patient care. Pharma IQ: The report highlights a shift from patient-centric campaigns to patient-led experiences in pharma communications. What do you think has …
We’re an award-winning specialist healthcare communications agency and founders of the Patient Advocacy & Centricity Tracker tool, as well as the global Patient Partnership Index.
OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO
OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO
